Our study will thus provide direct evidence of how CD4+ T cells interacting with B cells to participate in the pathogenesis of pristine-induced lupus in the mice, which may imply new strategies for SLE treatment. The gene discussed is CD4; the disease is systemic lupus erythematosus.